Campus to Nasdaq: Building a MedTech Leader Transforming Brain Care

Jane Chao, PhD ’05 is returning to campus to share her journey from Cornell researcher to co-founder and CEO of Ceribell, a Nasdaq-listed medtech company. Ceribell has developed a novel system for monitoring common neurological conditions in the ICU, such as seizure and delirium, enabling rapid diagnosis and sooner treatment.

In this public presentation, Chao will discuss:

• The problem Ceribell is tackling and how
• Her own entrepreneurial journey
• How PhD training helped her career

This free event is a great fit for life sciences researchers and students interested in entrepreneurship.